Stages of chronic kidney disease
Pro Research Analysisby 
Searched over 200M research papers
Stages of Chronic Kidney Disease (CKD)
Overview of Chronic Kidney Disease
Chronic Kidney Disease (CKD) is a progressive condition characterized by the gradual loss of kidney function over time. It is a significant global health issue, associated with increased risks of cardiovascular disease (CVD), premature mortality, and decreased quality of life Hill2016Levey2003. CKD is often asymptomatic in its early stages, making early detection and intervention crucial for preventing adverse outcomes Levey2003Levey2002.
Classification of CKD Stages
The classification of CKD is primarily based on the glomerular filtration rate (GFR) and the presence of kidney damage markers such as albuminuria. The National Kidney Foundation's Kidney Disease Outcomes Quality Initiative (K/DOQI) has established a five-stage system to categorize the severity of CKD Levey2003Levey2002.
Stage 1: Kidney Damage with Normal or Increased GFR
- GFR: ≥ 90 mL/min/1.73 m²
- Description: Kidney damage is present, often indicated by proteinuria (albumin-creatinine ratio > 30 mg/g) or other markers, but GFR remains normal or high Levey2003Levey2002.
- Prevalence: Approximately 3.5% globally .
Stage 2: Kidney Damage with Mild Decrease in GFR
- GFR: 60-89 mL/min/1.73 m²
- Description: Mild reduction in kidney function with evidence of kidney damage Levey2003Levey2002.
- Prevalence: Around 3.9% globally .
- Significance: Stage 2 is considered a critical tipping point where significant molecular changes, such as inflammation and tissue regeneration, become pronounced .
Stage 3: Moderate Decrease in GFR
- GFR: 30-59 mL/min/1.73 m²
- Description: Moderate reduction in kidney function without necessarily having symptoms Levey2003Levey2002.
- Prevalence: The most common stage, with a global prevalence of about 7.6% .
- Risks: Increased risk of progression to more severe stages, cardiovascular events, and mortality .
Stage 4: Severe Decrease in GFR
- GFR: 15-29 mL/min/1.73 m²
- Description: Severe reduction in kidney function, often accompanied by symptoms such as fatigue, swelling, and changes in urine output Levey2003Levey2002.
- Prevalence: Approximately 0.4% globally .
- Risks: High risk of progression to kidney failure, increased mortality, and hospitalization .
Stage 5: Kidney Failure
- GFR: < 15 mL/min/1.73 m² or on dialysis
- Description: Kidney function is severely compromised, requiring dialysis or transplantation for survival Levey2003Levey2002.
- Prevalence: Around 0.1% globally .
- Management: Immediate intervention with renal replacement therapy is necessary .
Importance of Early Detection and Management
Early detection and management of CKD are crucial to slow disease progression and mitigate complications. Routine laboratory tests can identify early stages of CKD, allowing for timely interventions such as blood pressure control, renin-angiotensin system inhibition, and lifestyle modifications Levey2003Levey2002Romagnani2017. Self-management programs have shown potential in improving patient outcomes, although more research is needed to establish their effectiveness conclusively .
Conclusion
CKD is a progressive disease with significant health implications. Understanding the stages of CKD and the importance of early detection and management can help reduce the burden of the disease and improve patient outcomes. Continued research and public health initiatives are essential to address the global impact of CKD effectively.
Sources and full results
Most relevant research papers on this topic
Prevalence of chronic kidney disease stages 3–5 in low- and middle-income countries in Asia: A systematic review and meta-analysis
Chronic kidney disease stages 3-5 prevalence in low- and middle-income countries in Asia is 11.2%, with high heterogeneity and potential for delayed progression through interventions.
Stage II of Chronic Kidney Disease—A Tipping Point in Disease Progression?
Stage 2 of chronic kidney disease is the tipping point in disease progression, with key events affecting inflammation, lipoprotein metabolism, angiogenesis, and tissue regeneration.
K/DOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification.
The K/DOQI clinical practice guidelines aim to define chronic kidney disease and classify its stages, aiming to improve early detection and treatment of the disease, potentially reducing complications and premature death.
Chronic kidney disease
Early detection and treatment of chronic kidney disease (CKD) can prevent complications and improve quality of life.
Progression to Stage 4 chronic kidney disease and death, acute kidney injury and hospitalization risk: a retrospective cohort study.
Progression from Stage 3 to Stage 4 chronic kidney disease is associated with increased risks of death, acute kidney injury, and hospitalization before end-stage renal disease.
DOI